from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0198c/zmp1

LFCtreatmentdescriptionclass of inhibitor

-1.188

Amikacinug/mL Amikacintranslation

-0.804

Cap5-10ug/mL Capreomycintranslation

-1.721

Rox10-50 ug/mL Roxithromycintranslation

-0.387

SM2-5 ug/mL Streptomycintranslation

-1.652

Tet5-10 ug/mL Tetracyclinetranslation

-0.221

Rif0.2-5ug/mL Rifampicintranscription

-0.708

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.614

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.116

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.220

Clofazimine10-13 ug/mL Clofaziminerespiration

0.333

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.851

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.659

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.067

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.434

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.021

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.200

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.370

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.428

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.264

KCN5-20 ug/mL Potassium cyaniderespiration

0.294

NaN30.2-2 mM Sodium aziderespiration

0.906

Nigericin50 uM Nigericinrespiration

-0.883

TRC10-150 ug/mL Triclosanrespiration

-0.501

TRZ10-25 ug/mL Thioridazinerespiration

-0.223

Valinomycin0.5-10 uM Valinomycinrespiration

0.676

ZnSO42 mM ZnSO4respiration

0.244

menadione6-10 ug/mL Menadionerespiration

-0.235

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.380

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.004

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.937

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.186

NRP_1Non-replicating persistence stage 1dosRassociated

0.437

Amp0.2mg/mL AmpicillincellWall

0.384

Cephalexin20-100 ug/mL CephalexincellWall

0.363

Cerulenin0.32-5 ug/mL CerulenincellWall

0.915

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.087

EMB10-20 ug/mL EthambutolcellWall

-0.429

Eta12-40 ug/mL EthionamidecellWall

-0.137

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.020

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.583

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.670

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.364

BZA0.12 mg/mL BenzamidearomaticAmides

0.307

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.154

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.026

H2O24 mM hydrogen peroxideDNAdamaging

-0.115

Levo10 ug/mL LevofloxacinDNAdamaging

0.975

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.811

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.295

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.642

UVUV-irradiationDNAdamaging

-1.837

ARP41-4 ug/mL Antitubercular compound ARP4?

0.342

Antimycin12.5-50 ug/mL Antimycin A?

0.650

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.664

PA_110-50 ug/mL Antitubercular compound PA-1?

0.922

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.158

PA8240.2-2 ug/mL PA-824?

-0.990

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.577

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.504

Verapamil50 uM Verapamil?

0.949

mercaptoethanol2 mM 2-Mercaptoethanol?

0.480

methoxatin10-20 ug/mL Methoxatin?